Search for: "Keys v. Johnson"
Results 361 - 380
of 1,141
Sort by Relevance
|
Sort by Date
19 Mar 2018, 6:55 am
By Marjorie Johnson, J.D. [read post]
19 Mar 2018, 3:30 am
” Painter v. [read post]
19 Mar 2018, 3:30 am
” Painter v. [read post]
15 Mar 2018, 4:27 am
In Hotak itself there was no criticism of the review decision in Mr Johnson’s case where the reviewing officer had used the adverb “significantly” without further elaboration. [read post]
13 Mar 2018, 8:35 am
YouTube, Johnson v. [read post]
13 Mar 2018, 7:20 am
Foreseeability is a key element.) [read post]
13 Mar 2018, 7:20 am
Foreseeability is a key element.) [read post]
8 Mar 2018, 7:57 am
Booker, Johnson v. [read post]
5 Mar 2018, 4:18 am
That is especially so when cost implications were a key part of the case for the appeal. [read post]
2 Mar 2018, 9:11 am
Consider, for example the case of Louis Milic, a computational stylistician, who studied the relative frequency of initial determiners and initial connectives in the sentences of Swift, Macaulay, Addison, Gibbon and Samuel Johnson. [read post]
2 Mar 2018, 9:11 am
Consider, for example the case of Louis Milic, a computational stylistician, who studied the relative frequency of initial determiners and initial connectives in the sentences of Swift, Macaulay, Addison, Gibbon and Samuel Johnson. [read post]
24 Feb 2018, 12:01 am
Supreme Court declared the Tenure of Office Act unconstitutional in its ruling in Myers v. [read post]
19 Feb 2018, 9:42 am
Bode or State v. [read post]
18 Feb 2018, 8:24 am
In Midler v. [read post]
17 Feb 2018, 7:31 am
"...It is now - key takeaways Not as greasy as some takeaways,the IPKat boxes up the lessonsof L'Oreal v RN VenturesOn the patent side of the case, there are five key takeaways from Mr Justice Carr's decision: Construction has been rebranded as "interpretation", thus emphasizing its more flexible role when we get to assessing equivalence under the new Actavis questions (or Lilly questions, depending on who you ask)… [read post]
7 Feb 2018, 2:53 am
Market Share Concentration The global IVD market is dominated by 8-10 key players: Roche Diagnostics Abbott Diagnostics (including Alere) Siemens Sysmex Ortho-Clinical Diagnostics (Johnson & Johnson diagnostic division) BioMerieux Danaher Thermo Fisher Becton Dickinson The IVD market is highly concentrated, with 9 companies generating 77% of the market revenue in 2016. [read post]
3 Feb 2018, 1:16 pm
Johnson. [read post]
2 Feb 2018, 7:04 am
Key Precedent Smith v. [read post]
30 Jan 2018, 4:16 pm
Webb v. [read post]
30 Jan 2018, 12:30 pm
Johnson v. [read post]
